GlassScriptPhysician profile
Ashley D Wiggins
NPI 1679872683
$478.49
in general payments reported to CMS, 2019-2025
16 companies · $392 in 2025
The $392 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.63 · 2023: $25.97 · 2024: $44.36 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $461.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $121.55 | 2025 | Mounjaro, Zepbound, Kisunla |
| Novo Nordisk INC | $66.77 | 2025 | Wegovy, Rybelsus, Ozempic |
| Corium, LLC | $46.98 | 2025 | Azstarys |
| Phathom Pharmaceuticals, INC. | $28.52 | 2025 | Voquezna |
| Abbvie INC. | $25.97 | 2023 | |
| Amgen INC. | $24.01 | 2024 | Repatha |
| Baxter Healthcare | $22.49 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Vanda Pharmaceuticals INC. | $21.48 | 2025 | Fanapt |
| Verona Pharma, INC. | $20.90 | 2025 | Ohtuvayre |
| Axsome Therapeutics, INC. | $20.35 | 2024 | Auvelity |
| Hologic Sales and Service, LLC | $17.32 | 2025 | Aptima |
| Tris Pharma INC | $17.14 | 2025 | Onyda Xr |
| Lundbeck LLC | $14.38 | 2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $14.00 | 2025 | Airsupra |
| Alexion Pharmaceuticals, INC. | $11.52 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $5.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Wiggins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.